NCT06680986 Echocardiographic Analysis by Artificial Intelligence in Hypertension
| NCT ID | NCT06680986 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Arterial Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2022-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2022-06-01 with a primary completion date of 2022-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to develop artificial intelligence (AI) tools to characterize cardiac remodelling in arterial hypertension through the analysis of routine imaging data (echocardiography) coupled with patient data. More precisely, this study will make it possible (i) to represent in a relevant way the spectrum of the cardiac repercussions of a population affected by hypertension to better characterize the progress of the pathology, in particular vis-à-vis the more ambiguous subjects to be characterized ("grey" area); (ii) to develop tools for the automatic quantification of cardiac function (segmentation and robust monitoring of the myocardium during the cardiac cycle, for the dynamic analysis of the shape and global deformation of the heart) and therefore to extract descriptors richer in cardiac function than those currently used in clinical routine.
Eligibility Criteria
Inclusion Criteria Patients who underwent a comprehensive blood pressure assessment during hospitalization in the Cardiologic Federation at Croix Rousse Hospital and Lyon Sud Hospital between January 2018 and December 2021. Exclusion Criteria Patients who are minors. Patients under curatorship or guardianship.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06680986 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Arterial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06680986 currently recruiting?
Yes, NCT06680986 is actively recruiting participants. Contact the research team at pierre-yves.courand@chu-lyon.fr for enrollment information.
Where is the NCT06680986 trial being conducted?
This trial is being conducted at Pierre-Bénite, France.
Who is sponsoring the NCT06680986 clinical trial?
NCT06680986 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 200 participants.